Clicky

Laboratorios Farmaceuticos Rovi S.A(41L)

Description: Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.


Keywords: Pharmaceutical Products Contract Manufacturing Services Diagnostic Imaging Syringe Heparins Enoxaparin Sodium Hospital Products Hirobriz Breezhaler Iomeron Iopamiro Multihance Pharmaceutical Forms Prohance Sonovue

Home Page: www.rovi.es

Calle JosE Isbert, 2
Madrid, 28223
Spain
Phone: 34 91 021 30 00


Officers

Name Title
Mr. Juan Lopez-Belmonte Encina Chairman & CEO
Mr. Ivan Lopez-Belmonte Encina Second Deputy Chairman & GM of Commercial and Development
Mr. Javier Lopez-Belmonte Encina First Deputy Chairman, GM of Industrial Operations & CFO
Ms. Marta Campos Martínez Head of Investor Relations
Ms. Mercedes Benítez del Castillo Sánchez Legal Department Manager
Ms. Beatriz Ávila Alcalde Sales Manager
Ms. Rosario Perucha Pérez Marketing Manager
Mr. Francisco Javier Angulo García Human Resources Manager
Mr. Gabriel Nunez Fernandez Secretary

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 37.4532
Trailing PE: 19.9842
Price-to-Book MRQ: 6.8066
Price-to-Sales TTM: 4.0801
IPO Date:
Fiscal Year End: December
Full Time Employees: 2111
Back to stocks